Yahoo Web Search

Search results

1. Verastem, Inc.

   NasdaqCM: VSTM

   2.9700

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +0.0100 (+0.34%)

   At close:4:00 PM EDTThu. Jul 25, 2024

   2.9600 -0.01 (-0.34%)

   After hrs:7:07 PM EDTThu. Jul 25, 2024

   Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	2.8500
     High	3.0000
     Low	2.8500

   • Mkt Cap	75.22M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	2.9600
     52 Wk. Low	2.5400
     52 Wk. High	14.2200

   More about VSTM

   Related stocks

   • KPTI
     Karyopharm Therapeutics Inc.
     KPTI
     0.9603
     +1.43%
   • TRVN
     Trevena, Inc.
     TRVN
     0.2281
     +1.24%
   • MRNS
     Marinus Pharmaceuticals, Inc.
     MRNS
     1.4150
     0.00%
   • VTVT
     vTv Therapeutics Inc.
     VTVT
     21.01
     -11.35%
   • RIGL
     Rigel Pharmaceuticals, Inc.
     RIGL
     10.90
     +3.51%

   More on Yahoo Finance

2. finance.yahoo.com › quote › VSTMVerastem, Inc. (VSTM) Stock Price, News, Quote & History - Yahoo...

   finance.yahoo.com › quote › VSTM

   • Cached

   Find the latest Verastem, Inc. (VSTM) stock quote, history, news and other vital information to help you with your stock trading and investing.

3. finance.yahoo.com › news › verastem-oncology-announces-proposed-public-200500583Verastem Oncology Announces Proposed Public Offering of Common ...

   finance.yahoo.com › news › verastem-oncology-announces-proposed-public-200500583

   • Cached

   2 days ago · BOSTON, July 23, 2024--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and ...

4. www.marketwatch.com › investing › stockVSTM Stock Price | Verastem Inc. Stock Quote (U.S.: Nasdaq ...

   www.marketwatch.com › investing › stock

   Jul 16, 2024 · VSTM | Complete Verastem Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

5. seekingalpha.com › symbol › VSTMVerastem, Inc. (VSTM) Stock Price, Quote, News & Analysis - ...

   seekingalpha.com › symbol › VSTM

   • Cached

   6 days ago · A high-level overview of Verastem, Inc. (VSTM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

6. stockanalysis.com › stocks › vstmVerastem, Inc. (VSTM) Stock Price, Quote & News - Stock Analysis

   stockanalysis.com › stocks › vstm

   • Cached

   Get a real-time Verastem, Inc. (VSTM) stock price quote with breaking news, financials, statistics, charts and more.

7. www.marketbeat.com › stocks › NASDAQVerastem (VSTM) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   6 days ago · Should You Buy or Sell Verastem Stock? Get The Latest VSTM Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

8. www.cnn.com › markets › stocksVSTM Stock Quote Price and Forecast | CNN

   www.cnn.com › markets › stocks

   • Cached

   Jun 26, 2023 · View Verastem, Inc. VSTM stock quote prices, financial information, real-time forecasts, and company news from CNN.

9. www.zacks.com › stock › quoteVerastem - VSTM - Stock Price Today - Zacks

   www.zacks.com › stock › quote

   • Cached

   6 days ago · Get the latest Verastem, Inc VSTM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

10. seekingalpha.com › news › 4110109-verastem-stock-rallies-on-positive-data-forVerastem stock rallies on positive data for pancreatic cancer...

    seekingalpha.com › news › 4110109-verastem-stock-rallies-on-positive-data-for

    May 23, 2024 · Shares of Verastem ( NASDAQ: VSTM) jumped 20% in post-market trading Thursday after the biotech company released positive interim data from a Phase 1/2 study of its drugs avutometinib and...

11. www.verastem.comVerastem Oncology | Biopharmaceutical Company

    www.verastem.com

    • Cached

    Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on exploring the unexplored to give patients diagnosed with cancer better options.